Related Experiment Videos
"Awakening" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics
1Clinical Neuroscience Research Center, San Diego, CA, USA.
The Journal of Clinical Psychiatry
|October 29, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The pharmacodynamic effects of combined administration of flibanserin and alcohol.
Journal of clinical pharmacy and therapeutics·2017
Innovative solutions to novel drug development in mental health.
Neuroscience and biobehavioral reviews·2013
Psychotherapy as an epigenetic 'drug': psychiatric therapeutics target symptoms linked to malfunctioning brain circuits with psychotherapy as well as with drugs.
Journal of clinical pharmacy and therapeutics·2012
The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man.
Journal of psychopharmacology (Oxford, England)·2011
Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics.
Journal of psychopharmacology (Oxford, England)·2009
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Acta psychiatrica Scandinavica·2009
Evaluation of Sexual Function With Adjunctive Lumateperone in Patients With Major Depressive Disorder.
The Journal of clinical psychiatry·2026
Electroconvulsive Therapy and All-Cause Mortality, Nonsuicide Mortality, and Suicide Mortality.
The Journal of clinical psychiatry·2026
Pharmacotherapies for Co-Occurring Stimulant Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Network Meta-Analysis.
The Journal of clinical psychiatry·2026
Time Trends in Maternal Attention-Deficit/Hyperactivity Disorder and Medication Use in Pregnancy.
The Journal of clinical psychiatry·2026
Decades After the NIH Revitalization Act: Persistent Gaps in Diversity of US Antidepressant Trials.
The Journal of clinical psychiatry·2026
The Prescriber's Guide to Oral Ketamine for Patients With Major Depressive Illness: Principles and Practice.
The Journal of clinical psychiatry·2026
Discontinuing extended-release buprenorphine: Participant experiences from a mixed-methods observational study.
Drug and alcohol dependence reports·2026